Medication info

Losartan Tablet (Losartan Potassium)

Prescription medicationTabletOralExpired
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Korea Pavice Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 200800642 · Notified 2008.01.17

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided into 2 oral doses per day or, if necessary, increased to 100 mg once daily. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Hypertension: If blood pressure is not controlled with this drug alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; it may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Korea Pavice Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension

  • Hypertension
  • Kidney disease
View approved original text

This medication is used to treat hypertension, particularly helping to prevent and treat kidney disease in patients with hypertension and type 2 diabetes. Therefore, it is effective for managing hypertension and its related kidney complications.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided into 2 oral doses per day or, if necessary, increased to 100 mg once daily. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this drug is 50 mg once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Hypertension: If blood pressure is not controlled with this drug alone, it may be administered in combination with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; it may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This drug should not be used by patients with allergic reactions, those who are pregnant, or patients with severely impaired liver function or certain hereditary diseases. Elderly patients, those with reduced kidney function, or patients at risk of rapid blood pressure drops should use this medication with special caution and have their blood pressure and kidney function monitored frequently. During treatment with this drug, dizziness or fatigue may occur, so caution is needed when driving or operating machinery. Since there is a risk of increased potassium levels, it should not be taken with potassium supplements or medications containing potassium, and it is important to regularly monitor serum potassium levels. This drug can affect liver and kidney function, so patients with liver or kidney disease may need dosage adjustments, and they should consult medical personnel immediately if any abnormal symptoms occur. There may be interactions when taken with other antihypertensive medications, certain analgesics, anticoagulants, etc., so it is essential to inform medical personnel about all other medications being taken. Overdosing this medication can lead to excessively low blood pressure and abnormalities in heart rhythm, so prescribed dosages and methods must be strictly followed. This drug has not been confirmed for safety and efficacy in children, especially those under six years of age or those with severely impaired kidney function. If any unusual symptoms or allergic reactions occur during treatment, discontinue use immediately and visit a medical facility. This medication should be stored out of the reach of children and should not be transferred to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 130 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distention
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • myasthenia
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • neuropathy
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory stagnation
  • thoracic discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • lethargy
  • thrombocytopenia
  • myalgia
  • fatigue
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased creatinine
  • increased BUN
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture and should be stored in a sealed container. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius to prolong its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.